Literature DB >> 2127981

Distal terminal axonopathy produced by 2,4-dithiobiuret: effects of long-term intoxication in rats.

Z Sahenk1.   

Abstract

It has been well established that 2,4-dithiobiuret (DTB) intoxication in rats produces a rapidly progressive hindlimb paralysis within days. The cause of this has, until recently, been explained on the basis of a physiological abnormality that involves a prejunctional impairment in the neuromuscular transmission alone. The morphological correlate of the electrophysiological abnormalities has now been provided. This study describes the sequential morphological alterations resulting from a chronic long-term DTB intoxication (1 mg/kg per day, IP) in the rat nervous system up to 48 days. The findings indicate that DTB neurotoxicity evolves as a central peripheral distal axonopathy initially affecting the motor nerve terminals which show accumulation of interconnecting branched tubulovesicular profiles. With continued exposure, nerve terminal swelling and degeneration took place. Similar pathological changes in distal axons were observed progressively involving the small intramuscular nerve bundles close to the nerve terminals. Central nervous system axons in the long descending tracts of spinal cord and the cerebellar vermis showed similar changes but to a lesser extent in later stage of intoxication.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127981     DOI: 10.1007/bf00334502

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone.

Authors:  K Saida; J R Mendell; H S Weiss
Journal:  J Neuropathol Exp Neurol       Date:  1976-05       Impact factor: 3.685

2.  REVERSIBLE PARALYSIS OF MOTOR FUNCTION IN RATS FROM THE CHRONIC ADMINISTRATION OF DITHIOBIURET.

Authors:  E B Astwood; A M Hughes; M Lubin; W P Vanderlaan; R D Adams
Journal:  Science       Date:  1945-08-24       Impact factor: 47.728

3.  Effects of 2,4-dithiobiuret treatment in rats on cholinergic function and metabolism of the extensor digitorum longus muscle.

Authors:  M H Weiler; K D Williams; R E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  1986-06-30       Impact factor: 4.219

4.  Infantile neuroaxonal dystrophy. A disease characterized by altered terminal axons and synaptic endings.

Authors:  E T Hedley-Whyte; F H Gilles; B G Uzman
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

5.  Dithiobiuret toxicity in the rat: evidence for latency and cumulative dose thresholds.

Authors:  W D Atchison; K H Yang; R E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  1981-11       Impact factor: 4.219

6.  Potential neuromuscular toxicity of 2,4-dithiobiuret in the rat.

Authors:  W D Atchison; R E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  1981-01       Impact factor: 4.219

7.  Dithiobiuret-induced muscle weakness in rats: evidence for a prejunctional effect.

Authors:  W D Atchison; W S Mellon; P M Lalley; R E Peterson
Journal:  Neurotoxicology       Date:  1982-07       Impact factor: 4.294

8.  Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons.

Authors:  P S Spencer; P K Thomas
Journal:  J Neurocytol       Date:  1974-12

9.  Temporal analysis of dithiobiuret neurotoxicity in rats and assessment of potential nonneural causes.

Authors:  K D Williams; M S Miller; B G Boysen; R E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  1987-11       Impact factor: 4.219

10.  Ultrastructural study of zinc pyridinethione-induced peripheral neuropathy.

Authors:  Z Sahenk; J R Mendell
Journal:  J Neuropathol Exp Neurol       Date:  1979-09       Impact factor: 3.685

View more
  1 in total

1.  Pathogenesis of autosomal dominant hereditary spastic paraplegia (SPG6) revealed by a rat model.

Authors:  Fumihiro Watanabe; William D Arnold; Robert E Hammer; Odelia Ghodsizadeh; Harmeet Moti; Mackenzie Schumer; Ahmed Hashmi; Anthony Hernandez; Amita Sneh; Zarife Sahenk; Yaz Y Kisanuki
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.